ong-term implantable continuous glucose monitor in type 1 diabetes

Not Applicable

• Conditions: Type 1 diabetes; Metabolic and Endocrine - Diabetes

• Registration Number: ACTRN12619000122156
• Lead Sponsor: St Vincent's Hospital Melbourne

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-01-29
• Last Update Posted: 15 July 2019

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 6

Inclusion Criteria

* Type 1 diabetes mellitus for at least 5 years
* c-peptide <150pmol/L
* HbA1c <10%
* BMI less than or equal to 35kg/m2

Exclusion Criteria

* Serious chronic illness
* Use of paracetamol during the trial

Study & Design

• Study Type: Interventional
• Study Design: Not specified